Transaction in Own Shares

Summary by AI ^BETAClose X

Legal & General Group Plc has purchased 8,087,004 ordinary shares between March 23rd and March 27th, 2026, as part of its share buyback program announced on March 11th, 2026. These repurchased shares will be cancelled, reducing the total number of ordinary shares in issue to 5,679,494,539, which also represents the total number of voting rights. The purchases were executed through Barclays Capital Securities Limited, with prices ranging from 229.20 pence to 244.30 pence per share.

Disclaimer*

Legal & General Group Plc

30 March 2026

LEGAL & GENERAL GROUP PLC
ISIN: GB0005603997
30^th March 2026

LEI number: 213800JH9QQWHLO99821

Legal & General Group Plc (the "Company")
Transaction in Own Shares

The Company announces that from 23^rd March 2026 up to and including 27^th March 2026 it had purchased a total of 8,087,004 of its ordinary shares of 2.5 pence each (the "ordinary shares"), through the Company's broker Barclays Capital Securities Limited as detailed below. The repurchased ordinary shares will be cancelled.

Date	Aggregate number of ordinary shares purchased	Highest price paid (per ordinary share)	Lowest price paid (per ordinary share)	Volume weighted average price	Trading venue
23^rd March 2026	681,614	238.50	229.50	236.41	XLON
23^rd March 2026	283,663	238.50	229.20	235.17	BATE
23^rd March 2026	287,121	238.50	229.50	234.87	TRQX
23^rd March 2026	232,512	238.50	229.60	236.09	AQXE
23^rd March 2026	515,090	238.50	229.20	235.23	CHIX
24^th March 2026	345,378	238.90	235.80	237.43	XLON
24^th March 2026	254,288	238.60	235.50	237.39	BATE
24^th March 2026	258,265	238.90	235.70	237.35	TRQX
24^th March 2026	56,989	238.80	236.00	237.51	AQXE
24^th March 2026	385,080	238.90	235.50	237.45	CHIX
25^th March 2026	338,565	244.20	241.90	243.07	XLON
25^th March 2026	151,692	244.30	241.80	243.33	BATE
25^th March 2026	179,661	244.30	241.90	243.19	TRQX
25^th March 2026	66,076	244.00	241.90	243.00	AQXE
25^th March 2026	264,006	244.30	241.90	243.23	CHIX
26^th March 2026	612,822	242.30	239.70	241.21	XLON
26^th March 2026	263,611	242.20	239.60	241.13	BATE
26^th March 2026	315,080	242.30	239.60	241.18	TRQX
26^th March 2026	170,510	242.30	239.70	241.23	AQXE
26^th March 2026	424,981	242.30	239.60	241.26	CHIX
27^th March 2026	522,581	242.70	239.40	240.65	XLON
27^th March 2026	364,226	242.70	239.40	240.62	BATE
27^th March 2026	404,744	242.70	239.40	240.62	TRQX
27^th March 2026	150,777	242.70	239.50	240.75	AQXE
27^th March 2026	557,672	242.70	239.40	240.64	CHIX

The purchases form part of the Company's share buyback programme announced on 11^th March 2026.

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 5,679,494,539 ordinary shares.

No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 5,679,494,539.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as incorporated into and implemented under English law (including by virtue of the European Union (Withdrawal) Act 2018), the detailed breakdown of individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the share buyback programme is set out below.

http://www.rns-pdf.londonstockexchange.com/rns/6780Y_1-2026-3-30.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END